Delivery Order SPE2DR25D2206-SPE2DR26F9PP0
Award Date 2/5/26
Potential Completion Date 2/27/26
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 10.8 mg implant syringes with a ceiling value of $6,055.80 under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. Ultimate completion date is February 27, 2026. No set-aside was used.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $1,985.82 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a specific procurement requirement under a broader contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $3,592.80. This firm fixed-price delivery order is scheduled for completion by February 19, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Zoladex 3.6 mg implant syringes, with a ceiling value of $3,971.64 and an ultimate completion date of October 14, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a contract ceiling value of $37,190. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency (DLA) awarded a $2,155.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Zoladex 3.6 mg implant syringes, with performance expected to conclude by February 19, 2026. The award was made on a non-set-aside, competitive basis and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order against AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zoladex 10.8 mg implant syringes, with a ceiling value of $2,789.25. This is a firm fixed-price delivery order with an ultimate completion date of October 1, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Zoladex 10.8 mg implant syringes, valued at $2,018.60. This firm fixed-price delivery order, which carries an ultimate completion date of February 20, 2026, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $2,018.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zoladex 10.8 mg implant syringes, with an ultimate completion date of February 10, 2026. This non-set-aside delivery order was awarded on January 20, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a critical...
- The Defense Logistics Agency awarded a $6,055.80 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zoladex 10.8 mg implant syringes, with final delivery required by January 29, 2026. This contract utilizes a firm fixed-price structure with no set-aside designation, reflecting a competitive award to the prime contractor. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9PP0Delivery Order
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for Zoladex 3.6 mg implant syringes, with a ceiling value of $2,155.68 and an ultimate completion date of February 27, 2026. Place of performance is Conshohocken, PA. The order was issued on a firm fixed price basis with no set-aside.
Generated 5/6/26, 12:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/4/26 |